Medscape

Octagam Withdrawn From Market Over Unresolved Blood Clots, Embolisms

September 24, 2010 — Octapharma USA is voluntarily withdrawing all lots of immune globulin G (IgG) intravenous (human) 5% liquid preparation (Octagam) in the United States while it investigates blood ...
Medindia

Octagam (5 gm) (Immune Globulin Intravenous ) Drug Price and Information

Immune Globulin Intravenous (Octagam (5 gm)) is a blood product administered intravenously, prescribed for primary immunodeficiency. GIV boosts the body's natural response in patients with compromised ...
EurekAlert!

ProDERM study results of Octagam® 10% treatment in patients with dermatomyositis published in the New England Journal of Medicine

LACHEN, Switzerland (Oct. 6, 2022) – Octapharma announced today the results from the ProDERM study on the efficacy and safety of Octagam ® 10% [Immune Globulin Intravenous (Human)], in adult ...
Business Wire

Octapharma USA Announces FDA Approval of Octagam 10%, Expanding Its Immune Globulin Therapy Portfolio

HOBOKEN, N.J.--(BUSINESS WIRE)--Octapharma USA today announced the U.S. Food and Drug Administration (FDA) has approved Octagam 10% [Immune Globulin Intravenous (Human) 10% (100 mg/mL) Liquid ...
ALZFORUM

Octagam®10%

The first trial of this IVIG preparation in Alzheimer's evaluated six different doses of Octagam 10 percent against two placebo comparators in a six-month trial of 58 people with mild to moderate AD.
FiercePharma

FDA Approves U.S. Market Return for octagam® Following

Product Expected to Be Available for Distribution in a Few Weeks HOBOKEN, N.J. (November 4, 2011) - The U.S. Food and Drug Administration (FDA) yesterday cleared the way for the U.S. market return of ...
EurekAlert!

Octapharma presents results of study on Octagam® 10% for severe COVID-19 patients at ASH

PARAMUS, N.J. (December 2, 2020) - Clinical research presented by Octapharma USA at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition will highlight the investigational use ...
Medindia

Octagam (1 gm) Injection

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
FiercePharma

Octapharma issues recall of one lot of its immune globulin Octagam

Switzerland’s Octapharma AG has issued an urgent, voluntary recall of one lot of its Octagam immune globulin used intravenously after several reports of allergic type skin reactions. The lot Octagam ...
News Medical

FDA grants seven years of marketing exclusivity for Octapharma’s Octagam 10%

Octapharma USA today announced the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) has awarded seven years of marketing exclusivity for Octagam ® 10% [Immune ...
Monthly Prescribing Reference

Octagam 10% Now Available for Chronic Immune Thrombocytopenic Purpura

Octapharma USA announced that Octagam 10% [Immune Globulin Intravenous (Human)] liquid preparation is available now for the treatment of adults with chronic immune thrombocytopenic purpura (ITP). The ...